期刊文献+

载基因支架治疗血管再狭窄 被引量:5

下载PDF
导出
摘要 血管局部定位基因转染是目前血管再狭窄基因治疗研究的热点,它将特异性基因精确定位转染至局部血管壁,实现外源性基因表达,从而最大限度地在血管局部发挥生物学效应。血管内支架作为一种局部定位并长期保留在体内的外源性植入物,是对血管内再狭窄进行基因治疗的比较理想的运载体系。
出处 《中国动脉硬化杂志》 CAS CSCD 2006年第1期83-85,共3页 Chinese Journal of Arteriosclerosis
  • 相关文献

参考文献30

  • 1Fischman DL,Leon MB,Baim DS,Schatz RA,Savage MP,Penn I,et al.A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease,Stent Restenosis Study Investigators[J].N Engl J Med,1994,331 (8):496-501 被引量:1
  • 2Serruys PW,Foley DP,Suttorp MJ,Rensing BJ,Suryapranata H,Materne P,et al.A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions:final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study[J].J Am Coll Cardiol,2002,39 (3):393-399 被引量:1
  • 3van den Brand MJ,Rensing BJ,Morel MA,Foley DP,de Valk V,Breeman A,et al.The effect of completeness of revascularization on event-free survival at one year in the ARTS trial[J].J Am Coll Cardiol,2002,39 (4):559-564 被引量:1
  • 4El-Omar MM,Dangas G,Iakovou I,Mehran R.Update on In-stent Restenosis[J].Curr Interv Cardiol Rep,2001,3 (4):296-305 被引量:1
  • 5Kipshidze N,Leon MB,Tsapenko M,Falotico R,Kopia GA,Moses J.Update on sirolimus drug-eluting stents[J].Curr Pharm Des,2004,10 (4):337-348 被引量:1
  • 6Stone GW,Ellis SG,Cox DA,Hermiller J,O'Shaughnessy C,Mann JT,et al.A polymer-based,paclitaxel-eluting stent in patients with coronary artery disease[J].N Engl J Med,2004,350 (3):221-231 被引量:1
  • 7Liistro F,Colombo A.Late acute thrombosis after paclitaxel eluting stent implantation[J].Heart,2001,86 (3):262-264 被引量:1
  • 8Yla-Herttuala S,Martin JF.Cardiovascular gene therapy[J].Lancet,2000,355 (9199):213-222 被引量:1
  • 9Mann MJ,Whittemore AD,Donaldson MC,Belkin M,Conte MS,Polak JF,et al.Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy:the PREVENT single-centre,randomised,controlled trial[J].Lancet,1999,354 (9189):1 493-498 被引量:1
  • 10Sharif F,Daly K,Crowley J,O'Brien T.Current status of catheter-and stent-based gene therapy[J].Cardiovasc Res,2004,64 (2):208-216 被引量:1

二级参考文献37

  • 1周玉杰,汪丽蕙,周爱儒,朱晓君,王文革,张晨辉,汤健.反义N-ras1基因对血管损伤后平滑肌细胞增殖的影响[J].中华医学杂志,1997,77(3):220-223. 被引量:8
  • 2Chang M W, Barr E, Liu M M, et al. Adenovirusmediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty[J]. J Clin Invest,1995, 96(5): 2260. 被引量:1
  • 3Asahara T, Bauters C, Pastore C, eta/. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery[J]. Circulation, 1995, 91(11): 2793. 被引量:1
  • 4Morishita R, Aoki M, Kaneda Y, et al. Gene therapy in vascular medicine: recent advances and future perspectives [J]. Pharmacol Ther, 2001, 91 (2): 105. 被引量:1
  • 5Elkon K B, Liu C C, Gall J G, et al. Tumor necrosis factor plays a central role in immune-mediated clearance of adenoviral vectors[J]. Proc Natl Acad Sci USA, 1997,94(18): 9814. 被引量:1
  • 6Zhang H G, Zhou T, Yang P, et al. Inhibition of tumor necrosis factor alpha decreases inflammation and prolongs adenovirus gene expression in lung and liver[J].Hum Gene Ther, 1998, 9(13): 1875. 被引量:1
  • 7Muul L M, Tuschong L M, Soenen S L, et al. Persistence and expression of the adenosine deaminase gene for twelve years and immune reaction to gene transfer components: Long-term results of the first clinical gene therapy trial[J], Blood, 2003, 101 (7): 2563. 被引量:1
  • 8Minter R M, Ferry M A, Murday M E, et al. Adenoviral delivery of human and viral IL-10 in murine sepsis [J]. J Immunol, 2001, 167(2): 1053. 被引量:1
  • 9Su E J, Stevenson S C, Rollence M, et al. A genetically modified adenoviral vector exhibits enhanced gene transfer of human smooth muscle cells [J]. J Vasc Res, 2001, 38(5): 471. 被引量:1
  • 10Yoshimura I, Ikegami S, Suzuki S, et al. Adenovirus mediated prostate specific enzyme prodrug gene therapy using prostate specific antigen promoter enhanced by the Cre-loxP system [J]. J Urol, 2002, 168(6):2659. 被引量:1

共引文献24

同被引文献58

  • 1赵安莎,张海燕,黄楠,张炳春,杨柯,李占全,赵红岩.载药复合支架的抗血管组织增生的研究[J].生物医学工程学杂志,2008,25(4):856-859. 被引量:6
  • 2Regar E,Serruys PW,Bode C,et al.Angiographic findings of the multicenter randomized study with the sirolimus-eluting bx velocity balloon-expandable stent(ravel)[J].Circulation,2002,106:1949-1956. 被引量:1
  • 3Cohen DJ,Bakhai A,Shi C,et al.Cost-effectiveness of sirolimus-eluting stents for treatment of complex coronary stenoses:results from the sirolimus-eluting balloon expandable stent in the treatment of patients With De Novo native coronary artery lesions(sirius)trial[J].Circulation,2004,110:508-514. 被引量:1
  • 4Wiemer M,Knig A,Rieber J,et al.Sirolimus-eluting stent implantation versus beta-irradiation for the treatment of in-stent restenotic lesions:clinical and ultrasound results from a randomised trial[J].Euro Intervention,2011,6:687-694. 被引量:1
  • 5von Neumann-Cosel P.Electron capture radioactive sources for intravascular brachytherapy:a feasibility study[J].Phys Med Biol,2003,48:1855-1862. 被引量:1
  • 6Sharif F,Daly K,Crowley J,O'Brien T.Current status of catheter-and stent-based gene therapy[J].Cardiovasc Res,2004,64 (2):208-216 被引量:1
  • 7Klugherz BD,Jones PL,Cui X,Chen W,Meneveau NF,DeFelice S,et al.Gene delivery from a DNA controlled-release stent in porcine coronary arteries[J].Nature Biotechnol,2000,18 (11):1 181-184 被引量:1
  • 8Mann MJ,Whittemore AD,Donaldson MC,Belkin M,Conte MS,Polak JF,et al.Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy:the prevent single-centre,randomised,controlled trial[J].Lancet,1999,354 (9189):1 493-498 被引量:1
  • 9Asahara T,Bauters C,Pastore C,Kearney M,Rossow S,Bunting S,et al.Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery[J].Circulation,1995,91 (11):2 793-801 被引量:1
  • 10Harvey BG,Maroni J,O'Donoghue KA,Chu KW,Muscat JC,Pippo AL,et al.Safety of local delivery of low-and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of morbid conditions[J].Hum Gene Ther,2002,13 (1):15-63 被引量:1

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部